Lv3
338 积分 2025-11-16 加入
The comings and goings of cell-free DNA: Biological and clinical implications
21天前
已完结
Liquid biopsies across the cancer care continuum
2个月前
已完结
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma
3个月前
已完结
Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients
3个月前
已完结
Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer
3个月前
已完结
Clonal Architecture ofEGFRMutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)
3个月前
已完结
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers
3个月前
已完结
Longitudinal monitoring of somatic genetic alterations in circulating cell‐free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors
3个月前
已完结
Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients
3个月前
已完结
EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non‐small cell lung cancer
3个月前
已完结
皖公网安备34019202002308
